Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-PRL Polyclonal Antibody

Catalog #:   PHB92901 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P01236
Overview

Catalog No.

PHB92901

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human PRL (Leu29-Cys227).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Prolactin, PRL

Purification

Purified by antigen affinity column.

Accession

P01236

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with PRL antibody (PHB92901) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 25 kDa
    Observed MW: 25 kDa
References

Active Immunization Against Inhibin Impaired Spermatogenesis, Plasma Luteinizing Hormone, Pituitary Prolactin mRNA, and Hypothalamic Vasoactive Intestinal Peptide mRNA Expressions in Yangzhou Ganders., PMID:40431506

A prolactin-targeting antibody to prevent stress-induced peripheral nociceptor sensitization and female postoperative pain., PMID:40354542

Prolactin maintains the neonatal phenotype of enterocytes during lactation in newborn mice., PMID:40353577

PRL-3: unveiling a new horizon in cancer therapy., PMID:40341216

Thyroid Diseases in Patients With Pituitary Neuroendocrine Tumours., PMID:40269579

Valproic acid promotes transcriptional activation of Drd2 by mediating histone acetylation to inhibit the mTOR-Pttg1 signaling axis and exerts anti-PitNETs activity., PMID:40220407

Targeting PFKFB4 Biomimetic Codelivery System Synergistically Enhances Ferroptosis to Suppress Small Cell Lung Cancer and Augments the Efficacy of Anti-PD-L1 Immunotherapy., PMID:40213972

IgA-type macroprolactin among 130 patients with macroprolactinemia., PMID:40195083

Primary Renal Lymphoma: A Single-Center Study of 14 Cases., PMID:39880694

Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreduction., PMID:39846984

Ontogeny of adenohypophyseal cells, pituitary gland development, and structure in adults of Astyanax lacustris (Teleostei, Characiformes): an emerging Neotropical model fish species., PMID:39821744

Immunization with OPN5 increased seasonal degradation of reproductive activity in Magang ganders., PMID:39754930

Preliminary urinary profiles of prolactin during gestation and the synergistic effects of embryonic diapause hormones in the giant panda (Ailuropoda melanoleuca)†., PMID:39657225

Impact of Laboratory-Measured Euthyroid Hashimoto's Thyroiditis on Reproductive Hormone Profile in Women with Obesity., PMID:39655636

[Combination of macro-TSH and macroprolactinemia phenomena in a patient with autoimmune thyroiditis and vitiligo]., PMID:39509634

Development of a high-throughput screening system targeting the protein-protein interactions between PRL and CNNM., PMID:39455715

Enhancing protective immunity against bacterial infection via coating nano-Rehmannia glutinosa polysaccharide with outer membrane vesicles., PMID:39315589

The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer., PMID:38898487

Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)., PMID:38841711

Hormones and B-cell development in health and autoimmunity., PMID:38680484

Macroprolactin in mothers and their babies: what is its origin?, PMID:38680064

Recombinant expression and characterization of Canine circovirus capsid protein for diagnosis., PMID:38659451

The early-stage clinical course of anti-pituitary-specific transcription factor-1 hypophysitis diagnosed post-immune checkpoint inhibitor treatment: A case with review of literature., PMID:38631695

Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer Signaling., PMID:38540761

Single-Molecule Two-Color Coincidence Detection of Unlabeled alpha-Synuclein Aggregates., PMID:38516037

Hashimoto's Thyroiditis Negatively Influences Intracytoplasmic Sperm Injection Outcome in Euthyroid Women on T4 Substitution Therapy: A Retrospective Study., PMID:38368857

Altered IgG4 antibody response to repeated mRNA versus recombinant protein SARS-CoV-2 vaccines., PMID:38360356

Simultaneous Detection of Prolactin and Growth Hormone Using a Dual-label Time-resolved Fluorescence Immunoassay., PMID:38349483

Protective effect of Inonotus obliquus polysaccharide on mice infected with Neospora caninum., PMID:38309392

Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition., PMID:38146732

Effects of Cetrorelix on Ovary and Endometrium Prior to Anti-PD-L1 Antibody in Murine Model., PMID:38103140

Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSF., PMID:38025276

Comparison of the Effects of Recombinant and Native Prolactin on the Proliferation and Apoptosis of Goose Granulosa Cells., PMID:38003565

Two-color coincidence single-molecule pulldown for the specific detection of disease-associated protein aggregates., PMID:37967183

Pan-PI3K inhibition with copanlisib overcomes Treg- and M2-TAM-mediated immune suppression and promotes anti-tumor immune responses., PMID:37935952

Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria., PMID:37919851

Development and characterisation of a novel inhibitory anti-GH monoclonal antibody., PMID:37855323

Anti-prolactin treatment alleviates lupus conditions by regulating the JAK2-STAT3 pathway., PMID:37727880

Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis., PMID:37715818

Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disorders., PMID:37698877

Anti-PRL-3 Monoclonal Antibody inhibits the Growth and Metastasis of colorectal adenocarcinoma., PMID:37670977

Aberrant HPO Axis Alterations and Autoimmune Abnormalities in PCOS Patients with DOR: A Retrospective Analysis., PMID:37629254

A new insight into GH regulation and its disturbance from nutrition and autoimmune perspectives., PMID:37544742

A Quadruplex Ultrasensitive Immunoassay for Simultaneous Assessment of Human Reproductive Hormone Proteins in Multiple Biofluid Samples., PMID:37489999

B cell depletion therapy does not resolve chronic active multiple sclerosis lesions., PMID:37437310

Clinical course of autoimmune thyroid diseases in women with prolactinomas: Results from a prospective study in a single tertiary centre., PMID:37268355

Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3., PMID:37220097

Thyroid Autoimmunity and Subclinical Hypothyroidism in Prolactinoma: A Case Control Study., PMID:37215267

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies., PMID:37060431

Single-Molecule Two-Color Coincidence Detection of Unlabeled alpha-Synuclein Aggregates., PMID:36762870

Datasheet

Document Download

Anti-PRL Polyclonal Antibody.pdf

 

$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-PRL Polyclonal Antibody [PHB92901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only